Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00569374 · ClinicalTrials.gov registry record · Phase 2
Safety and Tolerability of Modafinil for Methamphetamine Dependence
A Phase 2 study, sponsored by University of Arkansas.
- Completed
- Registry status
- Phase 2
- Development phase
- 8
- Enrollment target
NCT00569374: Completed Phase 2 study, sponsored by University of Arkansas.
NCT00569374 is a Phase 2 study that has completed, run by University of Arkansas. The registered enrollment target is 8 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00569374, a Phase 2 study, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 8 participants
- Enrollment target
Study Summary
This 7 week, open-label pilot clinical trial will examine the safety and tolerability of modafinil up to 400mg/day as a potential treatment to reduce methamphetamine use in methamphetamine-dependent volunteers.
Primary Outcome
Heart rate as a safety measure was measured by thrice weekly measuring heart rate in beats per minute.
Interventions
- DRUG Modafinil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2007-09 |
| Phase | Phase 2 |
What the finished NCT00569374 record still lists
NCT00569374 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Modafinil is the first listed.
NCT00569374 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00569374 about?
NCT00569374 is a clinical study titled "Safety and Tolerability of Modafinil for Methamphetamine Dependence". This 7 week, open-label pilot clinical trial will examine the safety and tolerability of modafinil up to 400mg/day as a potential treatment to reduce methamphetamine use in methamphetamine-dependent volunteers.
What is the current status of trial NCT00569374?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 8 participants. The study started on 2007-09.
What interventions are being tested in trial NCT00569374?
The interventions under investigation include: Modafinil (DRUG).
Who is sponsoring clinical trial NCT00569374?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00569374's enrollment target sits among peer trials
8 1990th of 2000 higher than 5 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia